Drug industry calls out telehealth company Hims & Hers' Super Bowl ad touting its knock-off weight loss medications.

We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it ...

We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to ...

Two sizable companies and a handful of small Asian issuers were listed in the US this past week. Read more here.

It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their US ...

Best yet, this growth isn't just coming from new customers. The revenue retention rate among Doximity's top 20 customers was ...

Deals, pipeline updates and geopolitical issues drove the conversation at the 2025 JP Morgan Healthcare conference.

Following rumblings of a private equity bidding war late last year, Bain Capital has emer | Bain Capital is laying out 510 ...

Sigma has recently consolidated a number of regional warehouses but still has excess warehouse capacity. While this leaves significant space for growth without further investment, and it is the ...

Eli Lilly on Thursday suggested that demand for its popular diabetes and weight-loss treatments was not a concern, easing ...

In much of the U.S., illegal cannabis outcompetes legal weed sold in licensed shops. For consumers, it can be difficult to ...

The main focus in Teva’s innovative portfolio continues to be neuroscience and immunology, with clinical trials for three key ...